Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study (Q41753328)
Jump to navigation
Jump to search
scientific article published on September 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study |
scientific article published on September 2014 |
Statements
1 reference
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study (English)
1 reference
Anne Szarewski
1 reference
S Rachel Skinner
2 references
Suzanne M Garland
1 reference
Wim Quint
1 reference
Myron J Levin
1 reference
Barbara Romanowski
1 reference
Eduardo Lazcano-Ponce
1 reference
Jorge Salmerón
1 reference
M Rowena Del Rosario-Raymundo
1 reference
René H M Verheijen
1 reference
Swee Chong Quek
1 reference
Daniel P da Silva
1 reference
Henry Kitchener
1 reference
Kah Leng Fong
1 reference
Céline Bouchard
1 reference
Deborah M Money
1 reference
Arunachalam Ilancheran
1 reference
Margaret E Cruickshank
1 reference
Archana Chatterjee
1 reference
Jack T Stapleton
1 reference
Mark Martens
1 reference
Marie-Pierre David
1 reference
Dorothée Meric
1 reference
Karin Hardt
1 reference
Dominique Descamps
1 reference
Brecht Geeraerts
1 reference
Frank Struyf
1 reference
Gary Dubin
1 reference
VIVIANE Study Group
1 reference
1 September 2014
1 reference
Identifiers
1 reference